Journal
Journal of Allergy and Clinical Immunology: In Practice
Publication Date
9-1-2023
Volume
11
Issue
9
First Page
2767
Last Page
2777
Document Type
Open Access Publication
DOI
10.1016/j.jaip.2023.05.023
Rights and Permissions
Krings JG, Sekhar TC, Chen V, Blake KV, Sumino K, James AS, Clover AK, Lenze EJ, Brownson RC, Castro M. Beginning to Address an Implementation Gap in Asthma: Clinicians' Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2767-2777. doi: 10.1016/j.jaip.2023.05.023. Copyright 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Krings, James G; Sekhar, Tejas C; Chen, Vanessa; Blake, Kathryn V; Sumino, Kaharu; James, Aimee S; Clover, Amber K; Lenze, Eric J; Brownson, Ross C; and Castro, Mario, "Beginning to address an implementation gap in asthma: Clinicians' views of prescribing reliever budesonide-formoterol inhalers and SMART in the United States." Journal of Allergy and Clinical Immunology: In Practice. 11, 9. 2767 - 2777. (2023).
https://digitalcommons.wustl.edu/oa_4/5331
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
